On December 25, 2015, Guizhou Xinbang Pharmaceutical Co., Ltd. (SZSE:002390) closed the transaction. The company amended terms of the transaction and issued 229,940,114 shares at CNY 8.35 per share for gross proceeds of CNY 1,919,999,951.90. The transaction completed registration procedures at China Securities Depository and Clearing Co., Ltd. Shenzhen Branch.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 CNY | +1.02% | +5.88% | -10.81% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.81% | 1.04B | |
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.16B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Guizhou Xinbang Pharmaceutical Co., Ltd. announced that it has received CNY 1.92 billion in funding from a group of investors